134 related articles for article (PubMed ID: 1527075)
1. Regulation of glucose transporters by connective tissue activating peptide-III isoforms.
Tai PK; Liao JF; Hossler PA; Castor CW; Carter-Su C
J Biol Chem; 1992 Sep; 267(27):19579-86. PubMed ID: 1527075
[TBL] [Abstract][Full Text] [Related]
2. Connective tissue activation. XXXVI. The origin, variety, distribution, and biologic fate of connective tissue activating peptide-III isoforms: characteristics in patients with rheumatic, renal, and arterial disease.
Castor CW; Andrews PC; Swartz RD; Ellis SG; Hossler PA; Clark MR; Matteson EL; Sachter EF
Arthritis Rheum; 1993 Aug; 36(8):1142-53. PubMed ID: 8343190
[TBL] [Abstract][Full Text] [Related]
3. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2.
Härter L; Petersen F; Flad HD; Brandt E
J Immunol; 1994 Dec; 153(12):5698-708. PubMed ID: 7989767
[TBL] [Abstract][Full Text] [Related]
4. Connective tissue activation. XXXIV: Effects of proteolytic processing on the biologic activities of CTAP-III.
Castor CW; Walz DA; Johnson PH; Hossler PA; Smith EM; Bignall MC; Aaron BP; Underhill P; Lazar JM; Hudson DH
J Lab Clin Med; 1990 Oct; 116(4):516-26. PubMed ID: 2212861
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils.
Reddigari SR; Kuna P; Miragliotta GF; Kornfeld D; Baeza ML; Castor CW; Kaplan AP
J Allergy Clin Immunol; 1992 Mar; 89(3):666-72. PubMed ID: 1372016
[TBL] [Abstract][Full Text] [Related]
6. Structure and bioactivity of recombinant human CTAP-III and NAP-2.
Proudfoot AE; Peitsch MC; Power CA; Allet B; Mermod JJ; Bacon K; Wells TN
J Protein Chem; 1997 Jan; 16(1):37-49. PubMed ID: 9055206
[TBL] [Abstract][Full Text] [Related]
7. Connective tissue activation. XXXV. Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell culture.
Castor CW; Smith EM; Hossler PA; Bignall MC; Aaron BP
Arthritis Rheum; 1992 Jul; 35(7):783-93. PubMed ID: 1622417
[TBL] [Abstract][Full Text] [Related]
8. Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases.
Car BD; Baggiolini M; Walz A
Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):581-4. PubMed ID: 2039437
[TBL] [Abstract][Full Text] [Related]
9. Thrombin-activated human platelets release two NAP-2 variants that stimulate polymorphonuclear leukocytes.
Piccardoni P; Evangelista V; Piccoli A; de Gaetano G; Walz A; Cerletti C
Thromb Haemost; 1996 Nov; 76(5):780-5. PubMed ID: 8950790
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein.
Ehlert JE; Ludwig A; Grimm TA; Lindner B; Flad HD; Brandt E
Blood; 2000 Nov; 96(9):2965-72. PubMed ID: 11049972
[TBL] [Abstract][Full Text] [Related]
11. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: interaction of NAP-2 with the NAP-1 receptor.
Leonard EJ; Yoshimura T; Rot A; Noer K; Walz A; Baggiolini M; Walz DA; Goetzl EJ; Castor CW
J Leukoc Biol; 1991 Mar; 49(3):258-65. PubMed ID: 1997632
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue activation: stimulation of glucose transport by connective tissue activating peptide III.
Castor CW; Furlong AM; Carter-Su C
Biochemistry; 1985 Mar; 24(7):1762-7. PubMed ID: 4005226
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of two glucose transporters by chronic growth hormone treatment of cultured 3T3-F442A adipose cells.
Tai PK; Liao JF; Chen EH; Dietz J; Schwartz J; Carter-Su C
J Biol Chem; 1990 Dec; 265(35):21828-34. PubMed ID: 2254335
[TBL] [Abstract][Full Text] [Related]
14. The amino-terminal residues in the crystal structure of connective tissue activating peptide-III (des10) block the ELR chemotactic sequence.
Malkowski MG; Lazar JB; Johnson PH; Edwards BF
J Mol Biol; 1997 Feb; 266(2):367-80. PubMed ID: 9047370
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III.
Brandt E; Van Damme J; Flad HD
Cytokine; 1991 Jul; 3(4):311-21. PubMed ID: 1873479
[TBL] [Abstract][Full Text] [Related]
16. Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils.
Walz A; Dewald B; von Tscharner V; Baggiolini M
J Exp Med; 1989 Nov; 170(5):1745-50. PubMed ID: 2681518
[TBL] [Abstract][Full Text] [Related]
17. Activation of human basophils through the IL-8 receptor.
Krieger M; Brunner T; Bischoff SC; von Tscharner V; Walz A; Moser B; Baggiolini M; Dahinden CA
J Immunol; 1992 Oct; 149(8):2662-7. PubMed ID: 1383321
[TBL] [Abstract][Full Text] [Related]
18. Novel C-terminally truncated isoforms of the CXC chemokine beta-thromboglobulin and their impact on neutrophil functions.
Ehlert JE; Gerdes J; Flad HD; Brandt E
J Immunol; 1998 Nov; 161(9):4975-82. PubMed ID: 9794434
[TBL] [Abstract][Full Text] [Related]
19. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases.
Walz A; Baggiolini M
J Exp Med; 1990 Feb; 171(2):449-54. PubMed ID: 2406364
[TBL] [Abstract][Full Text] [Related]
20. Sugar transport regulation: comparative characterization of the effect of NADH CoQ reductase deficiency in two cell culture systems.
Germinario RJ; Continelli L; Pratt S
Proc Soc Exp Biol Med; 2000 Nov; 225(2):116-22. PubMed ID: 11044253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
